Skip to main content
Fig. 1 | Thrombosis Journal

Fig. 1

From: Von Willebrand factor:antigen and ADAMTS-13 level, but not soluble P-selectin, are risk factors for the first asymptomatic deep vein thrombosis in cancer patients undergoing chemotherapy

Fig. 1

Patient selection and enrollment of the cohort study. A total of 246 patients diagnosed with cancer between November 2016 and February 2017 were initially evaluated for study enrollment. Of those, only 44 fulfilled the inclusion and exclusion criteria. Four patients were excluded due to various reasons, leaving only 40 cancer patients undergoing chemotherapy. Five patients (12.5%) developed asymptomatic DVT at the end of the observation period. Abbreviations: ALT, alanine transaminase; DVT, deep vein thrombosis; GFR, glomerular filtration rate; ULN, upper limit of normal value

Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us